|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
269 E Grand Ave,South San Francisco,California,US
|
|
Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. The target has been validated in a number of animal models and Cortexyme is currently moving a proprietary small molecule towards human clinical testing.
|
Cortexyme, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{last} | [email protected] |
75%
|
The widely used Cortexyme, Inc. email format is {last} (e.g. [email protected]) with 75% adoption across the company.
To contact Cortexyme, Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.